Surmodics Inc SRDX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if SRDX is a good fit for your portfolio.
News
-
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SRCL, IBTX, AGS, SRDX on Behalf of Shareholders
-
SURMODICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Surmodics, Inc. - SRDX
-
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ATRI, SRDX, AGS, VAPO on Behalf of Shareholders
-
STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Investigates Merger of Surmodics, Inc. – SRDX
-
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALIM, SRDX, ATRI on Behalf of Shareholders
-
STOCKHOLDER ALERT: The M&A Class Action Firm Investigates Merger of Surmodics, Inc. - SRDX
-
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HCP, SRDX, CALB, FFNW on Behalf of Shareholders
-
Kuehn Law Encourages, FFNW, HCP, CALB, and SRDX Investors to Contact Law Firm
Trading Information
- Previous Close Price
- $41.55
- Day Range
- $41.31–41.77
- 52-Week Range
- $25.17–42.44
- Bid/Ask
- $41.42 / $66.30
- Market Cap
- $591.16 Mil
- Volume/Avg
- 383,028 / 367,130
Key Statistics
- Price/Earnings (Normalized)
- 37.00
- Price/Sales
- 4.08
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Surmodics Inc is a provider of surface modification and in vitro diagnostic technologies to the healthcare industry. The company's mission is to improve the treatment and detection of disease by using its technology to provide solutions to difficult medical devices and diagnostic challenges. It has two reportable segments: Medical device unit; Manufacture of performance coatings, including surface modification coating technologies and the Vitro diagnostics unit; Manufacture of chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets. Surmodics derives majority of its revenue from the Medical Device segment.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 376
- Website
- https://www.surmodics.com
Comparables
Valuation
|
Metric
|
SRDX
|
300482
|
688067
|
|---|---|---|---|
Price/Earnings (Normalized) | 37.00 | 23.67 | 51.77 |
Price/Book Value | 4.77 | 2.12 | 1.83 |
Price/Sales | 4.08 | 3.87 | 4.37 |
Price/Cash Flow | 19.50 | 16.28 | 38.50 |
Price/Earnings
SRDX
300482
688067
Financial Strength
|
Metric
|
SRDX
|
300482
|
688067
|
|---|---|---|---|
Quick Ratio | 3.40 | 6.55 | 0.80 |
Current Ratio | 4.39 | 8.89 | 6.63 |
Interest Coverage | 5.87 | 19.42 | — |
Quick Ratio
SRDX
300482
688067
Profitability
|
Metric
|
SRDX
|
300482
|
688067
|
|---|---|---|---|
Return on Assets (Normalized) | 8.80% | 7.14% | 3.18% |
Return on Equity (Normalized) | 13.69% | 9.10% | 3.58% |
Return on Invested Capital (Normalized) | 12.48% | 7.91% | 3.50% |
Return on Assets
SRDX
300482
688067
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Lbfwmszfq | Chypnkv | $183.1 Bil | |||
| Stryker Corp
SYK
| Wspkhbwxj | Pllg | $126.3 Bil | |||
| Boston Scientific Corp
BSX
| Vrmcxlpr | Mxpml | $110.1 Bil | |||
| Medtronic PLC
MDT
| Tlnszjld | Fmvwgb | $100.9 Bil | |||
| Edwards Lifesciences Corp
EW
| Kmzxtljjtl | Pvfhvl | $37.6 Bil | |||
| DexCom Inc
DXCM
| Rqlldzdnh | Gjjv | $25.6 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Jpcdvmnsd | Tqbljyd | $24.1 Bil | |||
| Steris PLC
STE
| Xbgkytscx | Xvcfz | $23.0 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Bnksxxhxs | Lfkq | $22.9 Bil | |||
| Align Technology Inc
ALGN
| Rxjjhmjbm | Qmpld | $16.6 Bil |